Cargando…
Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy
Procalcitonin (PCT) is a biomarker for diagnosing infections and guiding antibiotic therapy. In this study, we investigated whether PCT can predict survival and recovery at 28 days in critically ill patients with sepsis-induced acute kidney injury (SIAKI) receiving continuous renal replacement thera...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794048/ https://www.ncbi.nlm.nih.gov/pubmed/36574383 http://dx.doi.org/10.1371/journal.pone.0279561 |
_version_ | 1784859953704468480 |
---|---|
author | Kim, Il Young Kim, Suji Ye, Byung Min Kim, Min Jeong Kim, Seo Rin Lee, Dong Won Lee, Soo Bong |
author_facet | Kim, Il Young Kim, Suji Ye, Byung Min Kim, Min Jeong Kim, Seo Rin Lee, Dong Won Lee, Soo Bong |
author_sort | Kim, Il Young |
collection | PubMed |
description | Procalcitonin (PCT) is a biomarker for diagnosing infections and guiding antibiotic therapy. In this study, we investigated whether PCT can predict survival and recovery at 28 days in critically ill patients with sepsis-induced acute kidney injury (SIAKI) receiving continuous renal replacement therapy (CRRT). We examined 649 patients with SIAKI who underwent CRRT in our intensive care unit. In a multivariable Cox regression analysis, a single PCT level at CRRT initiation was not associated with survival in all patients. However, the higher % PCT decrease over 72 hours after CRRT initiation was independently associated with the higher chance of 28-day survival (per 10% decrease, hazard ratio [HR] for mortality: 0.87, 95% confidence interval [CI]: 0.85–0.89; P < 0.001). Among the survivors, the % PCT decrease over 72 hours after CRRT initiation, not a single PCT level at CRRT initiation, was independently associated with recovery from dialysis (per 10% decrease, HR for renal recovery: 1.28, 95% CI:1.21–1.36; P < 0.001). This study demonstrated that the higher % PCT decrease was independently associated with the higher chance of survival and recovery from dialysis at 28 days in critically ill patients with SIAKI receiving CRRT. Thus, a decrease in the PCT level, not a single PCT level at CRRT initiation, could be a valuable tool for predicting prognosis in these patients. |
format | Online Article Text |
id | pubmed-9794048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97940482022-12-28 Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy Kim, Il Young Kim, Suji Ye, Byung Min Kim, Min Jeong Kim, Seo Rin Lee, Dong Won Lee, Soo Bong PLoS One Research Article Procalcitonin (PCT) is a biomarker for diagnosing infections and guiding antibiotic therapy. In this study, we investigated whether PCT can predict survival and recovery at 28 days in critically ill patients with sepsis-induced acute kidney injury (SIAKI) receiving continuous renal replacement therapy (CRRT). We examined 649 patients with SIAKI who underwent CRRT in our intensive care unit. In a multivariable Cox regression analysis, a single PCT level at CRRT initiation was not associated with survival in all patients. However, the higher % PCT decrease over 72 hours after CRRT initiation was independently associated with the higher chance of 28-day survival (per 10% decrease, hazard ratio [HR] for mortality: 0.87, 95% confidence interval [CI]: 0.85–0.89; P < 0.001). Among the survivors, the % PCT decrease over 72 hours after CRRT initiation, not a single PCT level at CRRT initiation, was independently associated with recovery from dialysis (per 10% decrease, HR for renal recovery: 1.28, 95% CI:1.21–1.36; P < 0.001). This study demonstrated that the higher % PCT decrease was independently associated with the higher chance of survival and recovery from dialysis at 28 days in critically ill patients with SIAKI receiving CRRT. Thus, a decrease in the PCT level, not a single PCT level at CRRT initiation, could be a valuable tool for predicting prognosis in these patients. Public Library of Science 2022-12-27 /pmc/articles/PMC9794048/ /pubmed/36574383 http://dx.doi.org/10.1371/journal.pone.0279561 Text en © 2022 Kim et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kim, Il Young Kim, Suji Ye, Byung Min Kim, Min Jeong Kim, Seo Rin Lee, Dong Won Lee, Soo Bong Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title | Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title_full | Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title_fullStr | Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title_full_unstemmed | Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title_short | Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
title_sort | procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794048/ https://www.ncbi.nlm.nih.gov/pubmed/36574383 http://dx.doi.org/10.1371/journal.pone.0279561 |
work_keys_str_mv | AT kimilyoung procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT kimsuji procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT yebyungmin procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT kimminjeong procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT kimseorin procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT leedongwon procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy AT leesoobong procalcitonindecreasepredictssurvivalandrecoveryfromdialysisat28daysinpatientswithsepsisinducedacutekidneyinjuryreceivingcontinuousrenalreplacementtherapy |